Two Herbs, One Question: Which Ayurvedic Cognitive Herb Fits the Need?
“Brain tonic” is too broad for a precise Ayurvedic choice. Poor retention, stress-related distractibility, disturbed sleep, mental fatigue, and progressive cognitive change are not interchangeable complaints. Brahmi and Shankhapushpi are both described as medhya in authoritative Ayurvedic sources, but their botanical identities, classical attributes, doses, and levels of modern clinical study differ substantially.
A second distinction is essential. The well-known passage in Charaka Samhita, Chikitsa Sthana 1/3/30–31, names Mandukaparni juice, Yashtimadhu powder with milk, Guduchi juice, and Shankhapushpi paste as especially intellect-promoting rasayanas. Bacopa monnieri is not one of the four drugs named in that passage. Nevertheless, the Ayurvedic Pharmacopoeia of India separately identifies Bacopa monnieri as Brahmi and assigns it the actions medhya and rasayana. Both herbs therefore have authentic Ayurvedic standing, but not through the same textual statement.
Brahmi (Bacopa monnieri): The Better-Studied Option for Memory
The Ayurvedic Pharmacopoeia of India defines Brahmi as the dried whole plant of Bacopa monnieri (Linn.) Wettst. Modern products may contain whole-plant powder or extracts standardized to selected saponins; these forms are not dose-equivalent and should not be treated as interchangeable.
Classical Ayurvedic Profile
Its recorded pharmacopoeial attributes are:
- Rasa: madhura, tikta, kashaya — sweet, bitter, and astringent
- Guna: laghu and sara — light and mobile or flowing
- Virya: shita — cooling
- Vipaka: madhura — sweet post-digestive effect
- Karma: includes medhya, rasayana, matiprada, Vatahara, and Kaphahara
The pharmacopoeia lists Sarasvatarishta, Brahmi Ghrita, Brahmi Vati, Sarasvata Churna, and Smritisagara Rasa among important formulations associated with Brahmi. Raw herb, extract capsules, and compound formulations remain therapeutically distinct.
Human Clinical Evidence
Bacopa has a larger human evidence base than Convolvulus pluricaulis. A 2001 randomized, double-blind, placebo-controlled trial of a standardized extract reported improvements after 12 weeks in visual information-processing speed, learning rate, memory consolidation, and state anxiety. A separate 2002 trial in adults aged 40–65 found a significant effect on retention of newly learned word pairs, with the pattern suggesting reduced forgetting rather than a broad improvement across every memory measure.
A 2012 systematic review found the most consistent signal in memory free recall, while effects in other cognitive domains were less consistent. A 2014 meta-analysis of randomized controlled trials concluded that Bacopa had potential cognitive benefits, particularly for speed of attention, while also calling for larger and better-designed trials. Standardized Bacopa extracts may improve selected outcomes in some adults after repeated use, but they are not established dementia treatments or universal remedies for poor concentration.
More recent evidence also argues against certainty. A 12-week randomized trial published in 2025 found no greater improvement in cognitive performance than placebo, although it reported signals for reduced stress and fatigue. Differences among extracts and study designs make product-specific interpretation important.
What Is Known About Mechanism
Bacopa contains dammarane-type triterpenoid saponins commonly grouped under the term bacosides. Laboratory and animal studies have examined antioxidant activity, cholinergic signaling, monoamine systems, synaptic plasticity, and neuroprotective pathways. Some human studies have also measured acetylcholinesterase-related outcomes. These findings do not justify equating Bacopa with donepezil or reducing its effects to one neurotransmitter pathway.
Shankhapushpi (Convolvulus pluricaulis): Classical Medhya Rasayana with Limited Human Data
The Ayurvedic Pharmacopoeia of India defines Shankhapushpi as the whole plant of Convolvulus pluricaulis Choisy. It also notes that Clitoria ternatea and Evolvulus alsinoides are used as Shankhapushpi in some parts of India. A label carrying the common name “Shankhpushpi” may therefore contain a different species from the one used in a study or monograph.
Classical Ayurvedic Profile
For pharmacopoeial Convolvulus pluricaulis, the recorded Ayurvedic attributes are:
- Rasa: tikta, kashaya — bitter and astringent
- Guna: sara — mobile or flowing
- Virya: shita — cooling
- Vipaka: madhura — sweet post-digestive effect
- Karma: includes medhya, rasayana, balya, ayushya, Kaphahara, Pittahara, and mohanashaka
Charaka’s medhya-rasayana passage specifies Shankhapushpi in paste form. The pharmacopoeia lists Brahmi Ghrita, Agastyaharitaki Rasayana, Brahma Rasayana, Manasamitra Vataka, Gorocanadi Vati, and Brahmi Vati among important formulations associated with Shankhapushpi. A formulation name containing “Brahmi” does not establish that every modern product contains both herbs.
Experimental Evidence and Its Limits
Animal studies have reported memory-related, anxiolytic, and central nervous system depressant effects from Convolvulus pluricaulis extracts. A 2011 study evaluated several extracts in rodents and found activity in learning, memory, anxiety, and locomotor models, with results varying by extract and dose. Phytochemical investigations describe alkaloids, coumarins, flavonoids, and sterols, with profiles varying by material and extraction method.
Human clinical evidence for authenticated Convolvulus pluricaulis remains sparse. It is therefore inaccurate to assign it a proven four-to-six-week onset, a validated GABA mechanism in patients, or superiority over Bacopa for anxiety. Its contemporary use is best framed as a classical Ayurvedic choice requiring individualized prescribing, not a standardized nootropic protocol.
Head-to-Head Comparison
No robust direct human trial establishes that one of these herbs is categorically superior to the other. A useful comparison separates classical pharmacopoeial information from modern clinical evidence.
| Parameter | Brahmi (Bacopa monnieri) | Shankhapushpi (Convolvulus pluricaulis) |
|---|---|---|
| Official drug part | Dried whole plant | Whole plant |
| Classical standing | Medhya and rasayana in the API monograph | One of Charaka’s four specified medhya rasayanas; also medhya and rasayana in the API |
| Rasa | Madhura, tikta, kashaya | Tikta, kashaya |
| Guna | Laghu, sara | Sara |
| Virya | Shita | Shita |
| Vipaka | Madhura | Madhura |
| Dosha-related API karma | Vatahara and Kaphahara are listed | Kaphahara and Pittahara are listed |
| API powder dose | 1–3 g | 3–8 g |
| Modern evidence | Several small human trials and systematic reviews; outcomes are mixed | Mainly animal and laboratory studies; limited authenticated human data |
| Common practical issue | Extract strengths and bacoside specifications differ | Several botanical species may be sold under the same common name |
Clinical Decision Framework
Ayurvedic selection should consider the person, the complaint, digestive tolerance, concurrent medicines, and the exact preparation. Constitution alone is insufficient, and neither herb should be chosen solely from an online dosha quiz.
When Brahmi May Be the More Defensible Starting Point
Brahmi is the more evidence-supported option when the goal is a time-limited trial for memory retention or selected attention outcomes in an otherwise medically assessed adult. Considerations include:
- Difficulty retaining newly learned information without sudden or progressive neurological symptoms
- A preference for a product standardized in the same way as a published human trial
- Willingness to use it consistently for the trial period rather than expecting an immediate stimulant effect
- Access to professional review of gastrointestinal tolerance, thyroid status, and possible medicine interactions
When Shankhapushpi May Be Considered
Shankhapushpi may be selected within an Ayurvedic plan when its classical medhya, rasayana, Pittahara, and Kaphahara profile fits the assessed presentation. Practical requirements are:
- Confirmation that the product contains Convolvulus pluricaulis rather than an unspecified substitute
- Use of the whole herb or a clearly characterized preparation rather than assuming all syrups are equivalent
- Practitioner supervision when the complaint includes anxiety, insomnia, seizures, thyroid disease, or regular medication use
- Realistic expectations, because a clinically validated onset time and comparative superiority have not been established
Should They Be Combined?
A combination is not automatically more effective. Classical and proprietary formulations may contain multiple medhya herbs, but their rationale, proportions, processing, and adjuvants are formulation-specific. A fixed schedule of 300 mg Bacopa extract plus 3 g Shankhapushpi is neither a universal classical protocol nor a validated combined regimen. Combination use should follow a qualified practitioner’s assessment.
Dosing and Dosage Forms
Dose must be tied to the exact material. A gram dose of whole-plant powder cannot be converted directly into a milligram dose of concentrated extract, and commercial syrups may also contain several ingredients.
Brahmi
The Ayurvedic Pharmacopoeia of India gives 1–3 g of the drug in powder form. Several adult cognition trials used about 300 mg daily of a particular standardized extract, but the extract specification is part of the dose and cannot be omitted. Brahmi Ghrita is an official classical formulation associated with the herb; its dose should follow the applicable formulary, product directions, and practitioner advice rather than being inferred from raw-herb dosing.
Shankhapushpi
The pharmacopoeial dose is 3–8 g of the drug in powder form. It does not establish a universal dose for juice, syrup, tablets, or concentrated extracts. Because several species circulate under the common name, check the botanical name and plant part.
Ghee, Milk, and Black Pepper
Ghee has an established place in Ayurvedic dietetics and in classical medicated-ghee formulations used for medhya purposes. That use does not prove that ghee increases absorption of every constituent in either herb. Likewise, adding black pepper is not automatically appropriate; piperine can alter drug metabolism, and no universal Brahmi–Shankhapushpi protocol requires it.
Safety Considerations and Interactions
“Natural” does not mean interaction-free. Product authentication, dose, duration, age, pregnancy status, medical conditions, and concurrent medicines all affect safety.
- Brahmi: Human trials most often report gastrointestinal effects such as increased stool frequency, abdominal cramps, and nausea. Caution is appropriate with thyroid disease or thyroid hormone, cholinergic or anticholinergic medicines, and drugs affected by CYP enzymes.
- Shankhapushpi: Human safety and interaction data for authenticated Convolvulus pluricaulis are limited. Do not use animal thyroid findings to alter levothyroxine, antithyroid medicine, or endocrine care.
- Pregnancy and breastfeeding: Avoid self-prescribing either herb because adequate human safety data and product consistency are lacking.
- Children and older adults: Dosing should be individualized by a qualified Ayurvedic practitioner or healthcare professional, especially when other medicines are used.
- Persistent symptoms: New, worsening, or progressive memory change, confusion, severe anxiety, sleep disruption, or functional decline requires medical evaluation rather than treatment with a nootropic supplement alone.
Consult a qualified Ayurvedic practitioner and the relevant healthcare provider before starting either herb, particularly if you are pregnant, breastfeeding, treating a thyroid or neurological condition, or taking prescription medication.
Bottom Line
Brahmi and Shankhapushpi are not interchangeable “brain herbs.” Bacopa monnieri has the stronger human research base for selected memory and attention outcomes, although results are mixed and extract-specific. Convolvulus pluricaulis has a particularly clear classical position as one of Charaka’s medhya rasayanas, but its modern human evidence is much thinner and botanical substitution is a major practical concern. The sound choice depends on authenticated material, the precise clinical goal, the Ayurvedic assessment, and safety review—not on claims of a universal best nootropic.
References
- Ayurvedic Pharmacopoeia of India
- Ayurvedic Pharmacopoeia of India
- Charaka Samhita — Buddhi
- The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects (2001), PubMed
- Chronic effects of Brahmi (Bacopa monnieri) on human memory (2002), PubMed
- The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials (2012), PubMed
- Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract (2014), PubMed
- The Effects of a Bacopa monnieri Extract (Bacumen(®)) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial (2025), PubMed
- Neuropharmacological review of the nootropic herb Bacopa monnieri (2013), PubMed Central
- Effects of 12-Week Bacopa monnieri Consumption on Attention, Cognitive Processing, Working Memory, and Functions of Both Cholinergic and Monoaminergic Systems in Healthy Elderly Volunteers (2012), PubMed
- Nootropic, anxiolytic and CNS-depressant studies on different plant sources of shankhpushpi (2011), PubMed
- Phytochemical Profile, Pharmacological Attributes and Medicinal Properties of Convolvulus prostratus – A Cognitive Enhancer Herb for the Management of Neurodegenerative Etiologies (2020), PubMed Central
- Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial (2010), PubMed
- NCBI
- Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4 (2002), PubMed
- Predicting Food-Drug Interactions between Piperine and CYP3A4 Substrate Drugs Using PBPK Modeling (2024), PubMed
I liked the practical side of Brahmi vs Shankhpushpi. Would be useful to see a short checklist next.
Your grandmother sounds like an amazing woman! Traditional knowledge passed through families is so precious
I work in clinical trials and I’ve seen some of these studies firsthand. The interpretations here are fair and measured. Well done
Has anyone else noticed the sleep improvement you mentioned? Ive been experiencing the same thing.
The methodological limitations section is what makes this article trustworthy. Any content that doesn’t acknowledge study limitations should be viewed skeptically.
The grandmothers always knew! I keep finding that traditional knowledge holds up to modern scrutiny.
The safest part of the Brahmi vs Shankhpushpi advice is keeping it simple. Would be useful to see a short checklist next.
I appreciate the discussion of what we don’t yet know as much as what we do. Scientific humility is undervalued in health communication
I came here to say exactly this and you said it better. Completely agree.
The safest part of the Brahmi vs Shankhpushpi advice is keeping it simple. A few more examples would still help.
The safety profiles described here are consistent with what’s in the peer-reviewed literature. I appreciate that adverse effects are discussed alongside benefits.
Thank you for sharing the practical tip about sourcing. That’s something I’ve been confused about.
The traditional knowledge systems described here had thousands of years of empirical observation. Modern science is essentially validating what healers learned through patient outcomes.
I liked the practical side of Brahmi vs Shankhpushpi. The examples make the advice less abstract.
I liked the practical side of Brahmi vs Shankhpushpi. This is the kind of detail readers can test slowly.
So encouraging to hear! Starting my first week and this is motivating me to stick with it.
I’m a medical student with interest in integrative approaches. Content like this bridges my two worlds of study and I’m grateful it exists.
I had the exact same confusion about this. Glad the article cleared it up for both of us
the mechanism explanations are fascinating. Understanding HOW these compounds work at a cellular level makes the traditional observations make much more sense.
thank you for sharing the practical tip about sourcing. That’s something I’ve been confused about
The distinction between Brahmi for retention versus Shankhpushpi for anxiety-related fog is genuinely useful — I’d been assuming they were interchangeable and just picked whichever was cheaper. Given that my issue is more concentration under deadline pressure than memory recall, it sounds like I’ve been taking the wrong one for months.
As a biomedical researcher I appreciate the careful distinction between correlation and causation in the studies cited here. More honest than most health content I read.
That’s a really important distinction you’ve made. I think a lot of people skip the preparation phase and then wonder why results are inconsistent.
The pitta-type caution for Shankhpushpi in excess was something I needed. I am pitta dominant and had headaches after high dose.
The biomarker studies cited here suggest mechanisms that go beyond placebo. That’s an important threshold for clinical credibility.
I’m a pharmacist and I share this kind of content with colleagues who are curious about herb-drug interactions. The safety discussion here is appropriately thorough.
I liked the practical side of Brahmi vs Shankhpushpi. This feels more usable than a long list of herbs.
Thank you for asking this! I’ve been too shy to ask the same question and I really needed this answered
This is the first comparison I’ve read that actually tells you which herb to choose rather than just listing both. Would Brahmi and Shankhpushpi interact negatively if someone took both, or is that a common combined approach in practice?
I have been taking Brahmi for memory since my first semester of medical school 4 years ago. The effect on learning retention was noticeable from month 2. Bacosides clearly do something. I started Shankhpushpi last year when I saw this article and the combination has a different character than Brahmi alone.
The safest part of the Brahmi vs Shankhpushpi advice is keeping it simple. Small daily changes are easier to follow than a perfect plan.
I would like more detail on Brahmi vs Shankhpushpi. A few more examples would still help.
Three months in, still waiting for the promised results. I’m not giving up yet but I’m managing my expectations now.
The discussion of standardization challenges in herbal medicine is something most popular articles skip entirely. Really important context for interpreting the research
appreciate the article but id need to see more clinical trials before changing my routine based on this
I take Bacopa for ADHD-adjacent attention issues. The slowing of processing speed initially noted in some trials was real for me in weeks 2-3 and then reversed by week 6. People who try it and stop in the early phase because of that initial sluggishness are missing the therapeutic window.
the concept is great but the execution could be better. A lot of ‘do this’ without explaining the why behind each step.
I think the article could be improved by addressing the quality control issues with Ayurvedic herbs. Heavy metal contamination is a real concern with unregulated products.
My mother has early cognitive decline and her neurologist approved Brahmi as an adjunct after reviewing the research. Six months in her performance on the MOCA test stayed stable while her neurologist expected decline. We are cautious about attributing this to Brahmi but the stability is encouraging.
Appreciate you keeping us honest. We’ve noted your feedback about dosage specificity and will address it in a revised version of this article.
The Shankhpushpi for exam anxiety angle is interesting. I have used it before high-stress presentations at work and noticed a calmer, cleaner mental state. It is less sedating than Ashwagandha and more compatible with needing to be sharp and present rather than just calm.
The quality variability in commercial Brahmi products is a real issue. I have tried 5 brands over 3 years and the effect ranges from noticeable to completely absent. Standardization to Bacosides is the minimum I look for but even standardized products vary in real-world effect.
The comparison of Brahmi and Shankhpushpi really clarifies why one herb might suit memory goals while the other fits stress related distractibility.
After menopause my word retrieval got noticeably worse. My neurologist said this is common hormonal cognitive change. I started Shankhpushpi based on this article’s description of its nervine properties and word-finding improved perceptibly within 5 weeks. May be placebo but the timing was notable.
I tried Brahmi for 3 months and experienced significant slowing of my mental speed. I work in finance where processing speed matters as much as retention. The memory improvement was real but the cost to speed was unacceptable for my work requirements. Shankhpushpi as a faster-acting option without that slowing effect may suit me better.
I wonder if the dosage range for Shankhpushpi (3 to 8 g) is practical for daily use in capsule form.
the article says Brahmi is cold in potency and Shankhpushpi is more neutral. as a Vata type who runs cold should I prefer Shankhpushpi over Brahmi? I have seen some practitioners recommend Brahmi for everyone regardless of constitution and I am not sure if the potency consideration is clinically significant.
From a neurological perspective the cholinesterase inhibiting activity of Bacopa at certain concentrations is pharmacologically meaningful. The mechanism research is more developed than for many other adaptogens. It doesn’t guarantee clinical efficacy but it explains why trials find cognitive effects.
The article points out that Bacopa monnieri isn’t listed in Charaka’s four medhya rasayanas, yet it still holds official medhya status.
Seeing the note about product authentication for Shankhpushpi makes me cautious about buying bulk powder online.
A practical takeaway is to match the herb to the specific complaint, like poor retention versus mental fatigue.
I appreciate the reminder that neither herb should be chosen based solely on an online dosha quiz.
The limited human data on Convolvulus pluricaulis means we should treat any anxiety claims as tentative.
For anyone experimenting with Brahmi extracts, checking the bacoside standardization seems essential before judging results.
Does timing matter, morning vs night, for these two herbs? I take Brahmi before bed but wondered if daytime would be better.
The children’s dosage section was missing. My son is 10 and his school performance has dropped. Are these safe for kids?
I’ve tried both and find Shankhpushpi gives me more brain clarity while Brahmi is better for sleep-related anxiety. Different mechanisms confirmed.
Late to this post but the comparison table summarizing both herbs saved me a lot of research time. Bookmarked.
Thanks!
I’ve been taking Brahmi for 6 months and noticed memory improvement but also slightly reduced motivation. Is this documented?
Does Brahmi dosage change with age? I’m 65 and wondering if the 300mg recommendation applies to elderly users.
I have ADHD and tried both herbs for 90 days each. Brahmi helped focus more. Shankhpushpi helped recall. Both useful, different mechanisms.
For someone dealing with exam stress who has never taken either, which would you say to start with? The decision matrix in section 4 helped but still unsure.
Same here
The section comparing bacosides vs shankhpushpine as active compounds was the most useful part for me.
The dosha-based recommendation at the end was decisive for me. Vata type with anxiety, Brahmi is clearly the right choice.
The difference in action timing, Shankhpushpi faster, Brahmi slower and sustained, is useful for setting expectations.
the ‘which is right for you’ framing implies self-diagnosis which can be risky. people should consult a vaidya first
Doing this
The Brahmi vs Shankhpushpi angle is useful here. Good starting point for a cautious reader.
Can these be combined or is it one or the other? The article implies either/or but I’ve seen combination products.
tried brahmi capsule vs powder and powder form works faster for me. does the article address bioavailability differences
Will try
does brahmi interact with thyroid medication? i take levothyroxine and want to know before starting
The quality variation between brands is massive. The guidance to look for standardized extract was the most practical takeaway.
Can this be combined with standard medication or is it better to do one at a time?
Bramhi gave me vivid dreams the first 2 weeks then stopped. Did anyone else experience this initial effect?
Shankhpushpi milk recipe you included has been my morning drink for 3 weeks. Concentration at work is noticeably better.
I was confused by different species being sold as Brahmi (Bacopa vs Centella). Your clarification of the species confusion was long overdue.
The approach described here is different from what my vaidya recommends. Is there a regional variation in this protocol?
I came here from the Instagram post. The article has way more detail than the summary. Bookmarked.